Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR34 | Q9UPC5 | 9/20 | 0.73 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | CTSL | P07711 | 1/20 | 0.59 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.59 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.58 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.58 |
| ▸ | KDM1A | O60341 | 1/20 | 0.57 |
| ▸ | MAOA | P21397 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7970010 | 1.00 | GPR34 (0.73) | GPR34PSMB5KMT2AMEN1ALDH1A1 | |
| SCHEMBL10727176 | 1.00 | GPR34 (0.73) | GPR34PSMB5KMT2AMEN1ALDH1A1 | |
| SCHEMBL11247627 | 0.92 | GPR34 (0.70) | GPR34PSMB5KMT2AMEN1ALDH1A1 | |
| SCHEMBL11247632 | 0.92 | GPR34 (0.70) | GPR34PSMB5KMT2AMEN1ALDH1A1 | |
| SCHEMBL27154066 | 0.90 | GPR34 (0.83) | GPR34KMT2AMEN1ALDH1A1LMNA | |
| SCHEMBL28965736 | 0.90 | GPR34 (0.69) | GPR34PSMB5KMT2AMEN1ALDH1A1 | |
| SCHEMBL10724456 | 0.90 | GPR34 (0.83) | GPR34KMT2AMEN1ALDH1A1LMNA | |
| SCHEMBL28965739 | 0.90 | GPR34 (0.69) | GPR34PSMB5KMT2AMEN1ALDH1A1 | |
| SCHEMBL8078373 | 0.88 | GPR34 (0.66) | GPR34PSMB5KMT2AMEN1ALDH1A1 | |
| SCHEMBL8078379 | 0.88 | GPR34 (0.66) | GPR34PSMB5KMT2AMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114645037-A | Means and methods for detoxification of ochratoxin A | 艾尔柏股份公司 | 2022-06-21 | — | — | CN | disclosed |
| EP-0264106-B1 | 5-Substituted amino-4-hydroxy-pentanoic acid derivatives and their use | BANYU PHARMA CO LTD (JP) | 1994-03-16 | — | — | EP | disclosed |
| US-4851387-A | RENIN INHIBITORS | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1989-07-25 | — | — | US | disclosed |
| EP-0264106-A2 | 5-Substituted amino-4-hydroxy-pentanoic acid derivatives and their use | Banyu Pharmaceutical Co., Ltd. (JP) | 1988-04-20 | — | — | EP | disclosed |
| US-4670584-A | PHENYLALANINE DERIVATIVES FOR INSULIN AND OTHER DRUGS | AJINOMOTO COMPANY INCORPORATED (JP) | 1987-06-02 | — | — | US | disclosed |
| US-4650785-A | ORAL ADMINISTRATION OF INSULIN | AJINOMOTO COMPANY INCOPORATED (JP) | 1987-03-17 | — | — | US | disclosed |
| EP-0093551-A2 | Pharmaceutical composition | AJINOMOTO CO., INC. (JP) | 1983-11-09 | — | — | EP | disclosed |